Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call reveals strong financial performance with increased income, lending growth, and high RoTE across divisions. Despite a single name impairment, the overall outlook remains positive, supported by strategic investments in technology and AI, and substantial shareholder returns planned. The Q&A session highlights management's confidence in NII growth and risk management, with no significant negative trends identified. The positive sentiment is further supported by record high revenues and optimistic guidance, suggesting a positive stock price movement in the short term.
Group RoTE 13.5% in Q1 2026, lower year-on-year due to stronger absolute earnings offset by 8% growth in tangible equity.
Top-line Growth 6% increase to GBP 8.2 billion, supported by NII growth and strong activity across the Investment Bank.
Cost-to-Income Ratio Improved to 56% from 57% a year earlier, driven by operational efficiency and GBP 150 million of gross efficiency savings.
RWAs in Investment Bank Increased modestly versus Q4 2025 to facilitate cyclical activity, with income surpassing GBP 4 billion for the first time.
CET1 Ratio 14.1%, consistent with the intention to operate around the top of the 13%-14% range, supported by strong organic capital generation of 53 basis points.
Impairment Charges GBP 823 million in Q1 2026, including a GBP 228 million single name charge related to a fraud case.
Loan Loss Rate 74 basis points in Q1 2026, with expectations to be around the top of the 50-60 basis points guidance for 2026.
U.K. Lending Growth 5% year-on-year, consistent with the 2025 exit rate, with GBP 22 billion deployed since 2024.
Mortgage Lending Grew by GBP 1.7 billion year-on-year, with application volumes increasing materially.
New Card Customers 364,000 added in Q1 2026, with balances growing 8% year-on-year.
U.K. Corporate Loans Grew by 15% year-on-year, split evenly between new and existing clients.
Barclays U.K. RoTE Increased to 19.7% year-on-year, with NII of GBP 2 billion growing 9% year-on-year.
Investment Bank RoTE 15% in Q1 2026, lower than last year due to a GBP 228 million impairment charge and fair value adjustments.
Markets Income Increased 13% year-on-year, with equities and FICC growing 23% and 8%, respectively.
Investment Banking Fees Increased 25% year-on-year, supported by an 89% growth in advisory fees and a 38% increase in ECM fees.
U.S. Consumer Bank RoTE 18.8% in Q1 2026, reflecting operational progress and a full quarter of income from the AAA portfolio.
U.S. Consumer Bank Receivables Grew 9% year-on-year, with half of the growth being organic.
Retail Deposit Balances Increased 8% quarter-on-quarter and 52% since the end of 2023.
Premier Wealth Management Launch: Barclays plans to launch Premier Wealth Management in the Barclays U.K. app in Q2 2026. This service will provide human-led, digitally enabled planning and advice, aiming to support fee growth beyond 2028.
U.K. Lending Growth: U.K. lending grew 5% year-on-year, consistent with the 2025 exit rate. Barclays remains on track to deploy approximately GBP 30 billion of U.K. business growth RWAs by the end of 2026.
International Corporate Bank Expansion: U.S. dollar deposits in the International Corporate Bank grew by 21% year-on-year. Barclays expects this division to become a larger part of the Investment Bank by 2028.
Operational Efficiency Savings: Barclays achieved approximately GBP 150 million of gross efficiency savings in Q1 2026, contributing to the GBP 2 billion target over three years.
iPortal Implementation: All corporate banking clients are now enabled on iPortal, a single management platform replacing five separate platforms. Full migration is expected during 2026, improving efficiency and supporting fee growth beyond 2028.
Risk Management Adjustments: Barclays is reducing exposure to highly leveraged non-investment grade corporates and constraining lending to structured finance counterparties with vulnerable business models due to increased macroeconomic uncertainties.
Inflationary Impact of Rising Energy Prices: Potential decline in consumption and growth due to inflationary pressures from rising energy prices.
Fraud in Securitized Products Business: A GBP 228 million single name charge due to a well-publicized sophisticated fraud, highlighting the importance of strong financial controls and the difficulty in identifying fraud beforehand.
Exposure to Structured Finance Counterparties: Constrained lending to certain structured finance counterparties with vulnerable business models and weak financial controls, as their risks outweigh potential rewards.
Highly Leveraged Non-Investment Grade Corporates: Reduced exposure to highly leveraged non-investment grade corporates due to their vulnerability to a weakening economy.
Macroeconomic and Business Uncertainties: Increased uncertainties in the macroeconomic environment, potentially impacting business operations and financial performance.
Motor Finance Provision: A GBP 105 million provision related to a motor finance business exited in 2019, reflecting higher compensatory interest rates and increased eligible cases under a revised redress scheme.
Loan Loss Rate Increase: Group loan loss rate expected to be around the top of the 50 to 60 basis points guidance for 2026, driven by impairments and economic uncertainties.
Revenue Expectations: Barclays expects to achieve a group income target of approximately GBP 31 billion by 2026, supported by stable income streams and growth in retail and corporate businesses.
Net Interest Income (NII): The company remains confident in delivering full-year guidance for group NII of more than GBP 13.5 billion, including GBP 8.1 billion to GBP 8.3 billion in Barclays U.K. Structural hedge income of GBP 18.3 billion is locked in for 2026-2028.
Cost-to-Income Ratio: Barclays aims to achieve a cost-to-income ratio in the high 50s by 2026, supported by GBP 2 billion in gross efficiency savings over three years.
Loan Loss Rate: The group expects a loan loss rate around the top of the 50 to 60 basis points through-the-cycle guidance in 2026. The U.S. Consumer Bank loan loss rate is projected at approximately 550 basis points for 2026.
U.K. Lending Growth: Barclays anticipates U.K. lending to grow at a compound annual growth rate (CAGR) of more than 5% from 2025 to 2028, with a target of deploying approximately GBP 30 billion of U.K. business growth RWAs by the end of 2026.
Investment Bank Performance: The Investment Bank aims to maintain consistent returns through RWA discipline, income stability, and operating leverage. It expects the International Corporate Bank to become a larger part of the Investment Bank by 2028.
U.S. Consumer Bank: The U.S. Consumer Bank expects a mid-40s cost-to-income ratio in 2026 and a net interest margin (NIM) of more than 13% for FY 2026, approaching 14% in the second half.
Capital Returns: Barclays plans to return at least GBP 15 billion to shareholders by 2028, including a GBP 500 million share buyback announced for Q1 2026.
Premier Wealth Management: The company plans to launch Premier Wealth Management in the Barclays U.K. app in Q2 2026 to drive fee growth beyond 2028.
Dividend Plan: Barclays plans to return at least GBP 15 billion to shareholders by 2028. This includes an accrual of GBP 500 million towards this year's GBP 2 billion dividend.
Share Buyback Program: Barclays announced a GBP 500 million share buyback for Q1 2026.
The earnings call reveals strong financial performance with increased income, lending growth, and high RoTE across divisions. Despite a single name impairment, the overall outlook remains positive, supported by strategic investments in technology and AI, and substantial shareholder returns planned. The Q&A session highlights management's confidence in NII growth and risk management, with no significant negative trends identified. The positive sentiment is further supported by record high revenues and optimistic guidance, suggesting a positive stock price movement in the short term.
The earnings call summary and Q&A session highlight positive financial performance with upgraded guidance, strong capital distribution plans, and continued growth in key areas like U.K. lending and U.S. Consumer Bank. The focus on efficiency savings and stable margins further supports a positive outlook. However, some concerns about rising loan loss ratios and competitive pressures exist, but overall sentiment remains positive due to strategic investments and shareholder return plans.
The earnings call highlights strong financial metrics, optimistic guidance, and strategic growth plans, such as achieving significant RoTE and efficiency savings. The Q&A section reveals confidence in risk management and growth in key areas like private banking. Despite some regulatory uncertainties and management's reluctance to provide specific future figures, the overall sentiment remains positive, with progressive shareholder returns and a focus on stable income streams. These factors suggest a positive stock price movement over the next two weeks.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.